Respiratory Syncytial Virus–Associated Lower Respiratory Tract Disease

Pediatric Respiratory Medicine

Volumn , Issue , 2008, Pages 491-499

  Everard, Mark L ^a  

^a SHEFFIELD CHILDREN S HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84857106971     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-032304048-8.50038-4     Document Type: Chapter

References (163)

1. American Academy of Pediatrics (2006) Subcommittee on Diagnosis and Management of Bronchiolitis: Clinical practice guideline: Diagnosis and management of bronchiolitis. Pediatrics 118 1774-1793.
2. L Bont, M Steijn, WM Van Aalderen, et al. (2004) Seasonality of long term wheezing following respiratory syncytial virus lower respiratory tract infection. Thorax 59 512-516.
3. JP Bradley, LB Bacharier, J Bonfiglio, et al. (2005) Severity of respiratory syncytial virus bronchiolitis is affected by cigarette smoke exposure and atopy. Pediatrics 115 e7-e14.
4. H Elphick, S Ritson, AS Rigby and ML Everard (2007) Phenotype of acute respiratory syncytial virus induced lower respiratory tract illness in infancy and subsequent morbidity. Acta Pediatr 96 307-309.
5. CB Hall and RG Douglas Jr (1981) Modes of transmission of respiratory syncytial virus. J Pediatr 99 100-103.
6. Hobson L, Everard ML: Persistent respiratory syncytial virus infection of human dendritic cells and activation of replication by exogenous nitric oxide. Clin Exp Immunol 2007 [Epub ahead of print].
7. D Hubble and GR Osborn (1941) Acute bronchiolitis in children. BMJ 1 107-110.
8. HW Kim, JO Arrabio, CD Brandt, et al. (1973) Epidemiology of respiratory syncytial virus infection in Washington, DC. 1. Importance of the virus in different respiratory tract disease syndromes and temporal distribution of infection. Am J Epidemiol 98 216-225.
9. ML Moore and RS Peebles Jr (2006) Respiratory syncytial virus disease mechanisms implicated by human, animal model, and in vitro data facilitate vaccine strategies and new therapeutics. Pharmacol Ther 112 405-424.
10. EOR Reynolds and CD Cook (1963) The treatment of bronchiolitis. J Pediatr 63 1205-1207.
11. AJ Martin, PS Gardner and J McQuillin (1978) Epidemiology of respiratory viral infection among paediatric inpatients over a six year period in North East England. Lancet 2 1035-1038.
12. HW Kim, JO Arrabio, CD Brandt, et al. (1973) Epidemiology of respiratory syncytial virus infection in Washington, DC. 1. Importance of the virus in different respiratory tract disease syndromes and temporal distribution of infection. Am J Epidemiol 98 216-225.
13. S Gilchrist, TJ Torok, HE Gary Jr, et al. (1994) National surveillance for respiratory syncytial virus, United States, 1985-1990. J Infect Dis 170 986-990.
14. S Leader and K Kohlhase (2003) Recent trends in severe respiratory syncytial virus (RSV) among US infants 1997 to 2000. J Pediatr 143(5 suppl), S127-S132.
15. KG Nicholson, T McNally, M Silverman, et al. (2006) Rates of hospitalisation for influenza, respiratory syncytial virus and human metapneumovirus among infants and young children. Vaccine 24 102-108.
16. DK Shay, RC Holman, RD Newman, et al. (1999) Bronchiolitis-associated hospitalizations among US children 1980-1996. JAMA 282 1440-1446.
17. JB van Woensel, WM van Aalderen, MC Kneyber, et al. (2002) Bronchiolitis hospitalisations in the Netherlands from 1991 to 1999. Arch Dis Child 86 370-371.
18. H Fransen, G Sterner, M Forsgren, et al. (1967) Acute lower respiratory illness in elderly patients with respiratory syncytial virus infection. Acta Med Scand 182 323-330.
19. CB Hall, JM Geiman, R Biggar, et al. (1976) Respiratory syncytial virus infections within families. N Engl J Med 294 414-419.
20. DM Fleming and KW Cross (1993) Respiratory syncytial virus or influenza. Lancet 342 1507-1510.
21. WW Thompson, DK Shay, E Weintraub, et al. (2003) Mortality associated with influenza and respiratory syncytial virus in the United States. JAMA 289 179-186.
22. AR Falsey, PA Hennessey, MA Formica, et al. (2005) Respiratory syncytial virus infection in elderly and high-risk adults. N Engl J Med 352 1749-1759.
23. K McIntosh and RM Chanock (2001) Respiratory syncytial virus. BM Fields, DM Knipe (Eds) Fields Virology 4th ed. Baltimore: Lippincott Williams & Wilkins
24. JM Bhatt and ML Everard (2004) Do environmental pollutants influence the onset of respiratory syncytial virus epidemics or disease severity? Paediatr Respir Rev 5 333-338.
25. PK Chan, RY Sung, KS Fung, et al. (1999) Epidemiology of respiratory syncytial virus infection among paediatric patients in Hong Kong: Seasonality and disease impact. Epidemiol Infect 123 257-262.
26. MW Weber, R Dackour, S Usen, et al. (1998) The clinical spectrum of respiratory syncytial virus disease in The Gambia. Pediatr Infect Dis J 17 224-230.
27. SE Vieira, KE Stewien, DA Queiroz, et al. (2001) Clinical patterns and seasonal trends in respiratory syncytial virus hospitalizations in Sao Paulo, Brazil. Rev Inst Med Trop Sao Paulo 43 125-131.
28. Hobson L, Everard ML: Persistent respiratory syncytial virus infection of human dendritic cells and activation of replication by exogenous nitric oxide.
29. JP Bradley, LB Bacharier, J Bonfiglio, et al. (2005) Severity of respiratory syncytial virus bronchiolitis is affected by cigarette smoke exposure and atopy. Pediatrics 115 e7-e14.
30. CB Hall and RG Douglas Jr (1981) Modes of transmission of respiratory syncytial virus. J Pediatr 99 100-103.
31. CB Hall (2000) Nosocomial respiratory syncytial virus infections: The “Cold War” has not ended. Clin Infect Dis 31 590-596.
32. DM Musher (2003) How contagious are common respiratory tract infections? N Engl J Med 348 1256-1266.
33. CB Hall, JM Geiman and RG Douglas Jr (1980) Possible transmission by fomites of respiratory syncytial virus. J Infect Dis 141 98-102.
34. CB Hall, RG Douglas Jr and JM Geiman (1976) Respiratory syncytial virus infections in infants: Quantitation and duration of shedding. J Pediatr 89 11-15.
35. WP Glezen, LH Taber, AL Frank, et al. (1986) Risk of primary infection and re-infection with respiratory syncytial virus. Am J Dis Child 140 543-546.
36. FW Henderson, AM Collier, WA Clyde, et al. (1979) Respiratory syncytial virus infections, reinfections and immunity. N Engl J Med 300 530-534.
37. WP Glezen, A Parades, JE Allison, et al. (1981) Risk of respiratory syncytial virus infection for infants from low income families in relationship to age, sex, ethnic group and maternal antibody level. J Pediatr 98 708-715.
38. M Green, AF Brayer, KA Schenkman, et al. (1989) Duration of hospitalisation in previously well infants with respiratory syncytial virus infection. J Pediatr Infect Dis 8 601-605.
39. JA McMillan, DA Tristram, LB Weiner, et al. (1988) Prediction of the duration of hospitalization in patients with respiratory syncytial virus infection: Use of clinical parameters. Pediatrics 81 22-26.
40. BJ Law, JM Langley, U Allen, et al. (2004) The Pediatric Investigators Collaborative Network on Infections in Canada study of predictors of hospitalization for respiratory syncytial virus infection for infants born at 33 through 35 completed weeks of gestation. Pediatr Infect Dis J 23 806-814.
41. K Meert, S Heidemann, M Lieh-Lai, et al. (1989) Clinical characteristics of respiratory syncytial virus infections in healthy versus previously compromised host. Pediatr Pulmonol 7 167-170.
42. BJ Law (1993) Respiratory syncytial virus infections in hospitalized Canadian children: Regional differences in patient populations and management practices. Pediatr Infect Dis J 12 659-663.
43. L Navas, E Wang and V de Carvalho (1992) Improved outcome of respiratory syncytial virus infection in a high-risk hospitalized population of Canadian children. J Pediatr 121 348-354.
44. M Eriksson, R Bennet, M Rotzen-Ostlund, et al. (2002) Population-based rates of severe respiratory syncytial virus infection in children with and without risk factors, and outcome in a tertiary care setting. Acta Paediatr 91 593-598.
45. E Rietveld, Y Vergouwe, EW Steyerberg, et al. (2006) Hospitalization for respiratory syncytial virus infection in young children: Development of a clinical prediction rule. Pediatr Infect Dis J 25 201-207.
46. LC Paramore, V Ciuryla, G Ciesla, et al. (2004) Economic impact of respiratory syncytial virus-related illness in the US: An analysis of national databases. Pharmacoeconomics 22 275-284.
47. HJ Wittig and J Glaser (1959) The relationship between bronchiolitis and childhood asthma: A follow-up study of 100 cases of bronchiolitis. J Allergy 30 19-23.
48. JC Rooney and HE Williams (1971) The relationship between proved viral bronchiolitis and subsequent wheezing. J Pediatr 79 744-747.
49. CR Pullan and EW Hey (1982) Wheezing, asthma and pulmonary dysfunction l0 years after infection with respiratory syncytial virus in infancy. Br Med J 284 1665-1669.
50. M Murray, MS Webb, C O'Callaghan, et al. (1992) Respiratory status and allergy after bronchiolitis. Arch Dis Child 67 482-487.
51. DG Sims, MAPS Downham, PS Gardner, et al. (1978) Study of 8 year old children with a history of respiratory syncytial virus bronchiolitis in infancy. BMJ 1 11-14.
52. DG Sims, et al. (1981) Atropy does not predispose to RSV bronchiolitis or post bronchiolitic wheezing. BMJ 282 2086-2088.
53. N Sigurs, R Bjarnason, F Sigurbergsson, et al. (1995) Asthma and immunoglobulin E antibodies after respiratory syncytial virus bronchiolitis: A prospective cohort study. Pediatrics 95 500-505.
54. N Sigurs, PM Gustafsson, R Bjarnason, et al. (2005) Severe respiratory syncytial virus bronchiolitis in infancy and asthma and allergy at age 13. Am J Respir Crit Care Med 171 137-141.
55. U Schauer, S Hoffjan, J Bittscheidt, et al. (2002) RSV bronchiolitis and risk of wheeze and allergic sensitisation in the first year of life. Eur Respir J 20 1277-1283.
56. L Bont, M Steijn, WM Van Aalderen, et al. (2004) Seasonality of long term wheezing following respiratory syncytial virus lower respiratory tract infection. Thorax 59 512-516.
57. M Korppi, E Piippo-Savolainen, K Korhonen, et al. (2004) Respiratory morbidity 20 years after RSV infection in infancy. Pediatr Pulmonol 38 155-160.
58. J Henderson, TN Hilliard, A Sherriff, et al. (2005) Hospitalization for RSV bronchiolitis before 12 months of age and subsequent asthma, atopy and wheeze: A longitudinal birth cohort study. Pediatr Allergy Immunol 16 386-392.
59. H Elphick, S Ritson, AS Rigby and ML Everard (2007) Phenotype of acute respiratory syncytial virus induced lower respiratory tract illness in infancy and subsequent morbidity. Acta Paediatr 96 307-309.
60. R Stein, D Sherrill, WJ Morgan, et al. (1999) Respiratory syncytial virus in early life and the subsequent risk of wheezing and allergic sensitization by age at 13. Lancet 354 541-545.
61. ML Everard (2006) The relationship between respiratory syncytial virus infections and the development of wheezing and asthma in children. Curr Opin Allergy Clin Immunol 6 56-61.
62. MC Zambon, JD Stockton, JP Clewley, et al. (2001) Contribution of influenza and respiratory syncytial virus to community cases of influenza-like illness: an observational study. Lancet 358 1410-1416.
63. A McGill, J Greensill, AW Craft, et al. (2004) Measurement of antibody against contemporary virus lineages of human respiratory syncytial virus sub-group A in infants and their mothers. J Clin Virol 30 73-80.
64. A McGill, J Greensill, R Marsh, et al. (2004) Detection of human respiratory syncytial virus genotype specific antibody responses in infants. J Med Virol 74 492-498.
65. Y Kuroiwa, K Nagai, L Okita, et al. (2005) A phylogenetic study of human respiratory syncytial viruses group A and B strains isolated in two cities in Japan from 1980-2002. J Med Virol 76 241-247.
66. ML Everard (2006) The role of the respiratory syncytial virus in airway syndromes in childhood. Curr Allergy Asthma Rep 6 97-102.
67. D Hubble and GR Osborn (1941) Acute bronchiolitis in children. BMJ 1 107-110.
68. R Henry, AD Milner and GM Stokes (1983) Bronchiolitis [letter]. Am J Dis Child 137 805.
69. PD Phelan, A Olinsky and CF Robertson (1994) Respiratory Illness in Children 4th ed. Oxford: Blackwell Scientific Publications 71-74.
70. CE Kuehni, Swiss Paediatric Pulmonology Group (2005) Phenotype specific treatment of obstructive airways disease in infancy and childhood: New recommendations of the Swiss Paediatric Pulmonology Group. Swiss Med Wkly 135 95-100.
71. KP Dawson, A Long, J Kennedy, et al. (1990) The chest radiograph in acute bronchiolitis. J Paediatr Child Health 26 209-211.
72. S Kern, M Uhl, R Berner, et al. (2001) Respiratory syncytial virus infection of the lower respiratory tract: Radiological findings in 108 children. Eur Radiol 11 2581-2584.
73. ML Everard, A Swarbrick, M Wrightman, et al. (1994) Analysis of cells obtained by bronchial lavage of infants with respiratory syncytial virus infection. Arch Dis Child 71 428-432.
74. PK Smith, SZ Wang, KD Dowling, et al. (2001) Leucocyte populations in respiratory syncytial virus-induced bronchiolitis. J Paediatr Child Health 37 146-151.
75. RB Turner (1990) The role of neutrophils in the pathogenesis of rhinovirus infections. Pediatr Infect Dis J 9 832-835.
76. M Abu-Harb, F Bell, WH Rao, et al. (1999) IL-8 and neutrophil inflammatory mediators in the upper respiratory tract of infants with RSV bronchiolitis. Eur Respir J 14 150-154.
77. GS Evans, A Jones, JM Qui, et al. (2002) Neutrophil survival is prolonged in the airways of healthy infants and infants with RSV bronchiolitis. Eur Respir J 20 651-657.
78. O Ruuskanen and PL Ogra (1993) Respiratory syncytial virus. Curr Probl Pediatr 23 50-79.
79. A Bush (2004) Phenotype specific treatment of asthma in childhood. Paediatr Respir Rev 5(suppl A), S93-S101.
80. G Wennergren, M Amark, K Amark, et al. (1997) Wheezing bronchitis reinvestigated at the age of 10 years. Acta Paediatr 86 351-355.
81. RF Lemanske Jr, DJ Jackson, RE Gangnon, et al. (2005) Rhinovirus illnesses during infancy predict subsequent childhood wheezing. J Allergy Clin Immunol 116 571-577.
82. A Kotaniemi-Syrjanen, A Laatikainen, M Waris, et al. (2005) Respiratory syncytial virus infection in children hospitalized for wheezing: Virus-specific studies from infancy to preschool years. Acta Paediatr 94 159-165.
83. MK Hyvarinen, A Kotaniemi-Syrjanen, TM Reijonen, et al. (2005) Teenage asthma after severe early childhood wheezing: An 11-year prospective follow-up. Pediatr Pulmonol 40 316-323.
84. M Korppi, A Kotaniemi-Syrjanen, M Waris, et al. (2004) Rhinovirus-associated wheezing in infancy: Comparison with respiratory syncytial virus bronchiolitis. Pediatr Infect Dis J 23 995-999.
85. PM Pitrez, S Brennan and PD Sly (2005) Inflammatory profile in nasal secretions of infants hospitalized with acute lower airway tract infections. Respirology 10 365-370.
86. DB Njoku and RM Kliegman (1993) Atypical extrapulmonary presentations of severe RSV infection requiring intensive care. Clin Pediatr 32 455-460.
87. MI Marks (1993) Respiratory syncytial virus infection: The expanded clinical spectrum. Clin Pediatr 32 461-462.
88. WV La Via, SW Grant, HR Stutman, et al. (1993) Clinical profile of pediatric patients hospitalised with respiratory syncytial virus infection. Clin Pediatr (Phila) 32 450-454.
89. DL Pickers, GL Schefft, GA Storch, et al. (1989) Characterisation of prolonged apnoeic episodes associated with respiratory syncytial virus infection. Pediatr Pulmonol 6 195-201.
90. M Rayyan, G Naulaers, H Daniels, et al. (2004) Characteristics of respiratory syncytial virus-related apnoea in three infants. Acta Paediatr 93 847-849.
91. DM Parham, R Cheng and GE Schutze (1998) Enzyme-linked immunoassay for respiratory syncytial virus is not predictive of bronchiolitis in sudden infant death syndrome. Pediatr Dev Pathol 1 375-379.
92. GW Fernald, JR Almond and F Henderson (1983) Cellular and humoral immunity in recurrent respiratory syncytial virus infections. Pediatr Res 17 753-758.
93. JV Mills, JE Van Kirk, PF Wright, et al. (1971) Experimental respiratory syncytial virus infection of adults. J Immunol 107 123-130.
94. MM Ogilvie, AS Vathenen, M Radford, et al. (1981) Maternal antibody and respiratory syncytial virus infection in infancy. J Med Virol 7 263-271.
95. KA Ward, AR Lambden, MM Ogilvie, et al. (1983) Antibody to respiratory syncytial virus polypeptides and their significance in human infection. J Gen Virol 64 1867-1876.
96. A Mejias, S Chavez-Bueno, AM Rios, et al. (2005) Comparative effects of two neutralizing anti-respiratory syncytial virus (RSV) monoclonal antibodies in the RSV murine model: time versus potency. Antimicrob Agents Chemother 49 4700-4707.
97. The IMpact-RSV Study Group (1998) Palivizumab, a humanized respiratory syncytial virus monoclonal antibody, reduces hospitalization from respiratory syncytial virus infection in high-risk infants. Pediatrics 102(3 Pt 1), 531-537.
98. TF Feltes, AK Cabalka and HC Meissner (2003) Palivizumab prophylaxis reduces hospitalization due to respiratory syncytial virus in young children with hemodynamically significant congenital heart disease. J Pediatr 14 532-540.
99. X Zhao and WM Sullender (2005) In vivo selection of respiratory syncytial viruses resistant to palivizumab. J Virol 79 3962-3968.
100. PF Wright, WC Gruber, M Peters, et al. (2002) Illness severity, viral shedding, and antibody responses in infants hospitalized with bronchiolitis caused by respiratory syncytial virus. J Infect Dis 185 1011-1018.
101. JP DeVincenzo, CM El Saleeby and AJ Bush (2005) Respiratory syncytial virus load predicts disease severity in previously healthy infants. J Infect Dis 191 1861-1868.
102. M Fishaut, D Tubergen and K McIntosh (1980) Cellular response to respiratory viruses with particular reference to children with disorders of cell mediated immunity. J Pediatr 96 179-186.
103. CB Hall, KR Powell and NE MacDonald (1986) Respiratory syncytial virus infection in children with compromised immune function. N Engl J Med 315 77-81.
104. ME Milner, SM de la Monte and GM Hutchins (1985) Fatal respiratory syncytial virus infection in severe combined immunodeficiency syndrome. Am J Dis Child 139 1111-1114.
105. B Viuff, K Tjornehoj and LE Larsen (2002) Replication and clearance of respiratory syncytial virus: Apoptosis is an important pathway of virus clearance after experimental infection with bovine respiratory syncytial virus. Am J Pathol 161 2195-2207.
106. HW Kim, JG Canchola, CD Brandt, et al. (1969) Respiratory syncytial virus disease in infants despite prior administration of antigenic inactivated vaccine. Am J Epidemiol 89 422-434.
107. RM Chanock, AZ Kapikian, J Mills, et al. (1970) Influence of immunological factors in respiratory syncytial virus disease of the lower respiratory tract. Arch Environ Health 21 347-355.
108. RC Welliver, M Sun, D Rinaldo, et al. (1986) Predictive valve of respiratory syncytial virus-specific IgE responses for recurrent wheezing following bronchiolitis. J Pediatr 109 776-800.
109. WH Alwan, FM Record and PJM Openshaw (1992) CD4+ve T cells clear virus but augment disease in mice infected with respiratory syncytial virus: Comparison with the effects of CD8+ve cells. Clin Exp Immunol 88 527.
110. S Kristjansson, SP Bjarnarson, G Wennergren, et al. (2005) Respiratory syncytial virus and other respiratory viruses during the first 3 months of life promote a local TH2-like response. J Allergy Clin Immunol 116 805-811.
111. ML Everard (1999) What link between early respiratory viral infections and atopic asthma? Lancet 354 527-528.
112. R Sharma and Z Woldehiwet (1991) Bovine respiratory syncytial virus: A review. Vet Bull 61 1117-1131.
113. TG Kimman, PJ Straver and GM Zimmer (1989) Pathogenesis of naturally acquired bovine respiratory syncytial virus in calves: Morphological and serologic findings. Am J Vet Res 50 684-693.
114. CE Behrendt, MD Decker, DJ Burch, et al. (1998) International variation in the management of infants hospitalized with respiratory syncytial virus. International RSV Study Group. Eur J Pediatr 157 215-220.
115. American Academy of Pediatrics (2006) Subcommittee on Diagnosis and Management of Bronchiolitis. Clinical practice guideline: Diagnosis and management of bronchiolitis. Pediatrics 118 1774-1793.
116. LJ Anderson, RA Parker and RL Strikas (1990) Association between respiratory syncytial virus outbreaks and lower respiratory tract deaths of infants and young children. J Infect Dis 161 640-646.
117. EEL Wang, BJ Law, D Stephens, et al. (1995) Pediatric Investigators Collaborative Network on Infections in Canada (PICNIC) prospective study of risk factors and outcomes in patients hospitalized with respiratory syncytial viral lower respiratory tract infection. J Pediatr 126 212-219.
118. M Stretton, SJ Ajizian, I Mitchell, et al. (1992) Intensive care course and outcome of patients infected with respiratory syncytial virus. Pediatr Pulmonol 13 143-150.
119. CB Hall, WJ Hall and DM Speers (1979) Clinical and physiological manifestions of bronchiolitis and pneumonia. Am J Dis Child 133 798-802.
120. EL Wang, RA Milner, L Navas, et al. (1992) Observer agreement for respiratory signs and oximetry in infants hospitalized with respiratory infections. Am Rev Respir Dis 145 106-109.
121. KN Shaw, LM Bell and NH Sherman (1991) Outpatient assessment of infants with bronchiolitis. Am J Dis Child 145 151-155.
122. EK Mulholland, A Olinski and FA Shann (1990) Clinical findings and severity of acute bronchiolitis. Lancet 335 1259-1261.
123. MO Titus and SW Wright (2003) Prevalence of serious bacterial infections in febrile infants with respiratory syncytial virus infection. Pediatrics 112 282-284.
124. CB Hall, KR Powell, K Schnabel, et al. (1988) The risk of secondary bacterial infection in infants hospitalised with respiratory syncytial virus infection. J Paediatr 113 266-271.
125. W Simpson, PM Hacking, SDM Court, et al. (1974) The radiological findings in respiratory syncytial virus infection in children. Part II: Correlation of radiological categories with clinical and virological findings. Pediatr Radiol 2 155-160.
126. HA van Steensel-Moll, JA Hazelet, E van der Voort, et al. (1990) Excessive secretion of antidiuretic hormone in infections with respiratory syncytial virus. Arch Dis Child 65 1237-1239.
127. S Hanna, SM Tibby, A Durward, et al. (2003) Incidence of hyponatraemia and hyponatraemic seizures in severe respiratory syncytial virus bronchiolitis. Acta Paediatr 92 430-434.
128. RP Wack, DM Demers and JW Bass (1994) Immature neutrophils in the peripheral blood smear of children with viral infections. Pediatr Infect Dis J 13 228-230.
129. EOR Reynolds and CD Cook (1963) The treatment of bronchiolitis. J Pediatr 63 1205-1207.
130. EOR Reynolds (1963) Arterial blood gas tensions in acute disease of lower respiratory tract in infancy. BMJ 1 1192-1195.
131. K Ventre and A Randolph (2004) Ribavirin for respiratory syncytial virus infection of the lower respiratory tract in infants and young children. Cochrane Database Syst Rev October 18(4),
132. AR Glanville, AI Scott, JM Morton, et al. (2005) Intravenous ribavirin is a safe and cost-effective treatment for respiratory syncytial virus infection after lung transplantation. J Heart Lung Transplant 24 2114-2119.
133. B Friis, P Andersen, E Brenoe, et al. (1984) Antibiotic treatment of pneumonia and bronchiolitis. Arch Dis Child 59 1038-1045.
134. MC Kneyber, B.H. van Oud-Alblas Blusse H, M van Vleit, et al. (2005) Concurrent bacterial infection and prolonged mechanical ventilation in infants with respiratory syncytial virus lower respiratory tract disease. Intensive Care Med 31 680-685.
135. K Thorburn, S Harigopal, V Reddy, et al. (2006) High incidence of pulmonary bacterial co-infection in children with severe respiratory syncytial virus (RSV) bronchiolitis. Thorax 61 611-615.
136. L Hartling, N Wiebe, K Russell, et al. (2004) Epinephrine for bronchiolitis. Cochrane Database Syst Rev (1), CD003123.
137. JD Kellner, A Ohlsson, AM Gadomski, et al. (2000) Bronchodilators for bronchiolitis. Cochrane Database Syst Rev (2), CD001266.
138. H Patel, R Platt, JM Lozano, et al. (2004) Glucocorticoids for acute viral bronchiolitis in infants and young children. Cochrane Database Syst Rev (3), CD004878.
139. C Perrotta, Z Ortiz and M Roque (2005) Chest physiotherapy for acute bronchiolitis in paediatric patients between 0 and 24 months old. Cochrane Database Syst Rev April 18(2), CD004873.
140. D Prais, T Schonfeld and J Amir Israeli Respiratory Syncytial Virus Monitoring Group (2003) Admission to the intensive care unit for respiratory syncytial virus bronchiolitis: A national survey before palivizumab use. Pediatrics 112(3 Pt 1), 548-552.
141. DK Shay, RC Holman, GE Roosevelt, et al. (2001) Bronchiolitis-associated mortality and estimates of respiratory syncytial virus-associated deaths among US children, 1979-1997. J Infect Dis 183 16-22.
142. JR Panickar, SR Dodd, RL Smyth, et al. (2005) Trends in deaths from respiratory illness in children in England and Wales from 1968 to 2000. Thorax 60 1035-1038.
143. NE MacDonald, C Bresse Hall, SC Suffin, et al. (1982) Respiratory syncytial viral infection in infants with congenital heart disease. N Engl J Med 307 397-400.
144. SW Turner, S Young, LI Landau and PN Le Souïf (2002) Reduced lung function both before bronchiolitis and at 11 years. Arch Dis Child 87 417-420.
145. H Richter and P Seddon (1998) Early nebulized budesonide in the treatment of bronchiolitis and the prevention of postbronchiolitic wheezing. J Pediatr 132 849-853.
146. A Cade, KG Brownlee, SP Conway, et al. (2000) Randomised placebo controlled trial of nebulised corticosteroids in acute respiratory syncytial viral bronchiolitis. Arch Dis Child 82 126-130.
147. M Kajosaari, P Syvanen, M Forars, et al. (2000) Inhaled corticosteroids during and after respiratory syncytial virus-bronchiolitis may decrease subsequent asthma. Pediatr Allergy Immunol 11 198-202.
148. H Bisgaard, Study Group on Montelukast and Respiratory Syncytial Virus (2003) A randomized trial of montelukast in respiratory syncytial virus postbronchiolitis. Am J Respir Crit Care Med 167 379-383.
149. K Sauer, E Goveaere, M Raes, et al. (2006) Montelukast is not preventing reactive airway disease in post respiratory syncytial virus bronchiolitis. Eur Respir J 28(suppl 50), 757s.
150. M McKean and F Ducharme (2000) Inhaled steroids for episodic viral wheeze of childhood. Cochrane Database Syst Rev (2), CD001107.
151. A Oommen, PC Lambert and J Grigg (2003) Efficacy of a short course of parent-initiated oral prednisolone for viral wheeze in children aged 1-5 years: Randomised controlled trial. Lancet 362 1433-1438.
152. R Chavasse, P Seddon, A Bara, et al. (2002) Short acting beta agonists for recurrent wheeze in children under 2 years of age. Cochrane Database Syst Rev (3), CD002873.
153. JM Leclair, J Freeman, BF Sullivan, et al. (1987) Prevention of nosocomial respiratory syncytial virus infections through compliance with glove and gown isolation precautions. N Engl J Med 317 329-334.
154. P Madge, JY Paton, JH McColl, et al. (1992) Prospective controlled study of four infection-contol procedures to prevent nosocomial infection with respiratory syncytial virus. Lancet 340 1079-1083.
155. JM Langley, JC LeBlanc, EE Wang, et al. (1997) Nosocomial respiratory syncytial virus infection in Canadian pediatric hospitals: A Pediatric Investigators Collaborative Network on Infections in Canada Study. Pediatrics 100 943-946.
156. NB Halasa, JV Williams, GJ Wilson, et al. (2005) Medical and economic impact of a respiratory syncytial virus outbreak in a neonatal intensive care unit. Pediatr Infect Dis J 24 1040-1044.
157. PA Piedra (2003) Clinical experience with respiratory syncytial virus vaccines. Pediatr Infect Dis J 22(2 suppl), S94-S99.
158. Moore ML, Peebles RS Jr: Respiratory syncytial virus disease mechanisms implicated by human, animal model, and in vitro data facilitate vaccine strategies and new therapeutics. Pharmacol Ther July 1, 2006.
159. JA Englund (1999) Prevention strategies for respiratory syncytial virus: Passive and active immunization. J Pediatr 135(2 Pt 2), 38-44.
160. HC Meissner, SS Long and American Academy of Pediatrics Committee on Infectious Diseases and Committee on Fetus and Newborn (2003) Revised indications for the use of palivizumab and respiratory syncytial virus immune globulin intravenous for the prevention of respiratory syncytial virus infections. Pediatrics 112 1447-1452.
161. ND Embleton, C Harkensee and MC Mckean (2005) Palivizumab for preterm infants. Is it worth it? Arch Dis Child Fetal Neonatal Educ 90 F286-F289.
162. S Wegner, JJ Vann, G Liu, et al. (2004) Direct cost analyses of palivizumab treatment in a cohort of at-risk children: Evidence from the North Carolina Medicaid Program. Pediatrics 114 1612-1619.
163. I Roeckl-Wiedmann, JG Liese, E Grill, et al. (2003) Economic evaluation of possible prevention of RSV-related hospitalizations in premature infants in Germany. Eur J Pediatr 162 237-244.